Ovid brings two Big Pharma vets on board as new CMO, head of epilepsy research
Ovid has hired two new senior employees to push its pipeline forward.
The New York-based, neuro-focused biotech put out word Wednesday morning that it hired Manoj Malhotra as its chief medical officer and Toshiya Nishi as its epilepsy research head.
Malhotra comes to Ovid after his stint at Eisai, where he was the head of medical affairs for Eisai’s neurology business group. Beyond Eisai, Malhotra is a neurologist and epileptologist who has had previous roles at Mallinckrodt, Novartis and Takeda.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.